RA
HNGE

Royce & Associates’s Hinge Health HNGE Stock Holding History

Royce & Associates’s Portfolio HNGE Stock Details HNGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
97,021
+52,010
+116% +$2.16M 0.04% 504
2025
Q4 		$2.09M Buy
+45,011
New +$2.17M 0.02% 583

Other funds holding HNGE

IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $143M AUM
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Royce & Associates's HNGE Position: Q1 2026 in Review

Royce & Associates increased its Hinge Health (HNGE) stake by 116% in Q1 2026, buying an estimated $2.16M and bringing the position to 97,021 shares worth $3.74M. The position accounts for 0.04% of the portfolio, ranked #504.

Royce & Associates first reported a position in HNGE in Q4 2025 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Royce & Associates held 97,021 shares of Hinge Health worth $3.74M as of Q1 2026.
  • Royce & Associates bought 52,010 Hinge Health shares in Q1 2026, an estimated $2.16M.
  • Hinge Health made up 0.04% of Royce & Associates's portfolio in Q1 2026, its #504 holding.
  • Royce & Associates first reported a position in Hinge Health in Q4 2025 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.